Join the Ulcerative Colitis group to help and get support from people like you.
Ulcerative Colitis News
Related terms: Colitis, Ulcerative, UC, Colitis Ulcerosa
Digital Model Based on Noninvasive Factors Shows Accuracy for Identifying IBD in Children
TUESDAY, July 22, 2025 – A model based on noninvasive tests shows high accuracy as a digital tool for the rapid identification of children with inflammatory bowel disease (IBD), according to a study...
Healthy Plant-Based Diet May Lower Inflammatory Bowel Disease Risk
WEDNESDAY, July 16, 2025 – A healthy plant-based diet may reduce the risk for inflammatory bowel disease (IBD) due to the anti-inflammatory properties of the diet, according to a study published...
Increase in Chronic Digestive Disorders Seen During Pandemic
WEDNESDAY, July 9, 2025 – There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study recently...
Most TikTok Videos on Inflammatory Bowel Disease Are Low Quality
FRIDAY, June 13, 2025 -- The most-viewed inflammatory bowel disease (IBD) videos on TikTok provide low-quality medical information, according to a study published online in the May/June issue ...
Inflammatory Bowel Disease Info Lacking On TikTok
WEDNESDAY, June 11, 2025 — Many folks with inflammatory bowel disease (IBD) are turning to TikTok for advice, but they aren’t likely to receive useful and accurate information, a new study says. Ana...
FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara
Guangzhou and London – May 27, 2025 – Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharm...
Monthly News Roundup - March 2025
FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (guselkumab) for the t...
Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD
MONDAY, March 24, 2025 – Among people with inflammatory bowel disease (IBD), conditions developed at or before age 60 years and their age of onset are important for predicting premature death,...
IBD Activity May Increase Risk for Clostridioides Difficile Infection
WEDNESDAY, March 5, 2025 – For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage,...
Inflammatory Bowel Disease Tied to Higher Risk for Heart Disease
WEDNESDAY, Feb 5, 2025 – Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study published in the March issue of...
Metrics From Wearable Devices Can Predict IBD Flares
FRIDAY, Jan. 24, 2025 – Physiological metrics from wearable devices can help identify inflammatory bowel disease (IBD) flares, according to a study published online Jan. 16 in Gastroenterology....
Intestinal Ultrasound Feasible for Detecting Pediatric Inflammatory Bowel Disease
FRIDAY, Jan. 3, 2025 – Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according to a study published online Dec. 24 in the Journal of ...
Upadacitinib Improves Ulcerative Colitis Outcomes at 12 Months
MONDAY, Dec. 23, 2024 – For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study...
FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara
JERSEY CITY, N.J., Dec. 17, 2024 – Celltrion announced today that the U.S. Food and Drug Administration (FDA) has approved Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), for...
FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
Bengaluru, Karnataka, India, December 01, 2024 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced ...
Further information
Related condition support groups
Ulcerative Colitis - Active, Colitis
Related drug support groups
Humira, clonidine, hydrocortisone, Entyvio, Stelara, Remicade, Xeljanz, Skyrizi, dexamethasone, adalimumab, budesonide, ustekinumab, Tremfya